Medical Developments International | MVP - Des Atouts

Prix De L'Action
0.39
Variation Quotidienne
0.01 2.63%
Mensuellement
-14.29%
Annuel
-40.00%
Q1 Prévisions
0.40




Des Atouts Changement Date
Akebia Therapeutics USD 376.56M 12.41M 2025-12
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
Avita Medical AUD 56.39M 1.74M 2025-12
Clinuvel Pharmaceuticals AUD 231.12M 19.44M 2024-06
Dianthus Therapeutics USD 530.92M 46.52M 2025-12
Genetic Signatures AUD 49.04M 5.59M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Organon & Co USD 13.55B 52M 2025-09
Paradigm Biopharmaceuticals AUD 24.57M 10.79M 2025-06
PYC Therapeutics AUD 159.13M 24.15M 2025-12
Starpharma Holdings AUD 26.17M 746K 2025-12
Tectonic Therapeutic USD 277M 18.31M 2025-09
Telix Pharmaceuticals AUD 1.16B 25.97M 2025-12
Viatris USD 37.19B 727.3M 2025-12
Xeris Pharmaceuticals USD 370.19M 35.5M 2025-09